Literature DB >> 11575436

Differential effects of nucleoside analogs on oxidative phosphorylation in human pancreatic cells.

G Lake-Bakaar1, V Mazzoccoli, K Dickman, S Lyubsky.   

Abstract

Although nucleoside analogs as a group inhibit mtDNA replication, individually they target specific organs for toxicity. For example, dideoxyinosine (ddI) is most closely associated with clinical pancreatitis and dideoxycytosine (ddC) with peripheral neuropathy. Comparison of the differential effects of these analogs on mitochondrial function in relevant human cell lines could provide general clues as to the mechanisms of their differential toxicity. We compared the effects of ddI [and its intracellular metabolite dideoxyadenosine (ddA)], with other nucleoside analogs ddC, Azidothymidine (AZT) and didehydrodeoxythymidine (d4T) on mtDNA elongation, cytotoxicity, oxidative phosphorylation, and cellular ATP concentration in a human pancreatic cell line, Capan-1 cells. AZT, like all the other analogs tested, altered mtDNA elongation, but had no other effect on these cells. Both ddC and d4T, but not ddI (20 microm and 50 microM), reduced total dish protein (a measure of cell numbers) in cells grown to confluence. The effect of ddA was intermediate. All (except AZT) increased lactate concentration in the cell culture medium. Dideoxycytosine (ddC) and d4T did not significantly affect cell oxygen consumption, expressed as a fraction of total dish protein. By contrast, ddI and ddA reduced basal and/or FCCP-stimulated oxygen consumption. Dideoxycytosine (ddC) but not ddI or ddA (50 microM) was cytotoxic to cells after six days of growth. Nevertheless, the ATP content (expressed as a fraction of surviving cells) for ddC-, ddI-, and ddA-treated cells was similar to control cells. Cytotoxicity was apparent for ddI, ddA, as well as ddC after seven days. Paradoxically, cell ATP content was now significantly higher than control cells. Electron microscopy of cells treated with ddI confirmed significant ultrastructural changes affecting the inner mitochondria membrane and cristae. In conclusion, these data suggest that nucleoside analogs uniformly induce damage to mtDNA. However, the mitochondrial phenotypic damage induced by ddI and ddA appear to result in less Capan-1 cytotoxicity than ddC and d4T. The link between these differential effects and ddI pancreatitis is unclear.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11575436     DOI: 10.1023/a:1010618627594

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  17 in total

1.  The Friend murine erythroleukemia cell, a model system for studying the association between bone marrow toxicity induced by 3'-azido-3'-dideoxythymidine and dideoxynucleoside inhibition of mtDNA replication.

Authors:  G A Hobbs; S A Keilbaugh; M V Simpson
Journal:  Biochem Pharmacol       Date:  1992-04-01       Impact factor: 5.858

2.  Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis.

Authors:  J L Martin; C E Brown; N Matthews-Davis; J E Reardon
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

3.  Effect of nucleoside analogs on neurite regeneration and mitochondrial DNA synthesis in PC-12 cells.

Authors:  L Cui; L Locatelli; M Y Xie; J P Sommadossi
Journal:  J Pharmacol Exp Ther       Date:  1997-03       Impact factor: 4.030

4.  Differential effects of respiratory inhibitors on glycolysis in proximal tubules.

Authors:  K G Dickman; L J Mandel
Journal:  Am J Physiol       Date:  1990-06

5.  Cellular targets of 3'-azido-3'-deoxythymidine: an early (non-delayed) effect on oxidative phosphorylation.

Authors:  G A Hobbs; S A Keilbaugh; P M Rief; M V Simpson
Journal:  Biochem Pharmacol       Date:  1995-07-31       Impact factor: 5.858

6.  Analysis of potential risk factors associated with the development of pancreatitis in phase I patients with AIDS or AIDS-related complex receiving didanosine.

Authors:  T H Grasela; C A Walawander; M Beltangady; C A Knupp; R R Martin; L M Dunkle; R H Barbhaiya; K A Pittman; R Dolin; F T Valentine
Journal:  J Infect Dis       Date:  1994-06       Impact factor: 5.226

7.  Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model.

Authors:  L Lamperth; M C Dalakas; F Dagani; J Anderson; R Ferrari
Journal:  Lab Invest       Date:  1991-12       Impact factor: 5.662

8.  The use and toxicity of didanosine (ddI) in HIV antibody-positive individuals intolerant to zidovudine (AZT)

Authors:  G J Moyle; M R Nelson; D Hawkins; B G Gazzard
Journal:  Q J Med       Date:  1993-03

9.  Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus dideoxynucleosides.

Authors:  D J Medina; C H Tsai; G D Hsiung; Y C Cheng
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

10.  Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity.

Authors:  T D Anderson; A Davidovich; D Feldman; T J Sprinkle; J Arezzo; C Brosnan; R O Calderon; L H Fossom; J T DeVries; G H DeVries
Journal:  Lab Invest       Date:  1994-05       Impact factor: 5.662

View more
  3 in total

1.  Mitochondrial Toxicity Associated with Nucleoside Reverse Transcriptase Inhibitor Therapy.

Authors:  Cecilia M. Shikuma; Bruce Shiramizu
Journal:  Curr Infect Dis Rep       Date:  2001-12       Impact factor: 3.725

2.  Acute pancreatitis associated with interferon and ribavirin therapy in patients with chronic hepatitis C.

Authors:  Swati Chaudhari; James Park; Bhupinderjit S Anand; Neville R Pimstone; Douglas T Dieterich; Steven Batash; Edmund J Bini
Journal:  Dig Dis Sci       Date:  2004-06       Impact factor: 3.199

3.  NRTI backbone in HIV treatment: will it remain relevant?

Authors:  Randall Tressler; Catherine Godfrey
Journal:  Drugs       Date:  2012-11-12       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.